AzTrials
AzTrials

Cardiovascular DiseaseCARDIVEGNCT02641834

Prevention of Cardiovascular Disease With Med or Veg Diets

A study testing Vegetarian diet and Mediterranean diet in people with Cardiovascular Disease, run by Azienda Ospedaliero-Universitaria Careggi at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study is a randomized, open, cross-over trial designed to test whether a vegetarian diet would benefit the cardiovascular risk profile of the participants, compared with a Mediterranean diet. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Cardiovascular Disease
What is being tested?
Vegetarian diet and Mediterranean diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
118 participants
Where
1 siteItaly
Study dates
Jan 2016to Dec 2016
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 18-75 years
  • Willing and able to give informed consent
  • Presence of at least one of the following risk factors for cardiovascular disease (European Society of Cardiology guidelines on cardiovascular disease prevention):
  • BMI >o= 25 kg/m2
  • Waist circumference > 88 cm (women) or > 102 cm (men)
  • Circulating levels of total cholesterol > 190 mg/dL, non-drug treatment (measured no more than 3 months prior to the start of the study)
Show all 13Show fewer
  • Circulating levels of LDL cholesterol > 115 mg/dL, non-drug treatment (measured no more than 3 months prior to the start of the study)
  • Levels of circulating triglycerides > 150 mg/dL, non-drug treatment (measured no more than 3 months prior to the start of the study)
  • Circulating levels of fasting blood glucose > 110 and < 126 mg/dL, non-drug treatment (measured no more than 3 months prior to the start of the study)
  • Wiling to participate in a randomized study comparing two dietary profiles, one of which is a vegetarian dietary pattern
  • Successfully completed 3-day food diary
  • Wiling to be contacted at least twice during the study period to evaluate diet compliance
  • Wiling to provide blood and fecal samples

Who cannot join

  • Presence of current serious illness or unstable condition that requires physician supervision of diet or physical activity (e.g., recent myocardial infarction, chronic liver disease, inflammatory bowel diseases)
  • Pregnancy or intention to become pregnant in next 18 months
  • Lactation
  • Current or recent (past 6 months) participation in weight loss treatment program or use of weight loss medication
  • Reporting no regular intake of meat, fish, or poultry for past month

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Unit of Clinical Nutrition, University Hospital of Careggi

    Florence, 50134

Other trials in Italy

About this study

Official title: Prevention of Cardiovascular Disease With the Vegetarian Diet: the CARDIVEG Study

The study is a randomized, open, cross-over trial designed to test whether a vegetarian diet would benefit the cardiovascular risk profile of the participants, compared with a Mediterranean diet.

Read the detailed description

Nutrition is able to substantially alter the health status of the general population. In industrialized countries such as Italy the most important association between diet and health is certainly the relationship with cardiovascular disease, the leading cause of death and disability. The ability to identify with certainty, therefore, the relationship between diet and cardiovascular disease appears to be a key element in the implementation of specific primary prevention strategies.

Cardiovascular diseases would be the result of interactions between genetics and environmental factors. Many studies have evaluated the associations between food groups, foods, or nutrients and chronic diseases, and a consensus about the role of nutritional factors in the etiology of common diseases, such as cardiovascular and neoplastic diseases, has gradually emerged. Recent studies have been focused on examining the impact of a whole dietary approach rather than on isolating single nutrients; it is recognized that analyses of single nutrients ignore the important and complex interactions between components of a diet and, more importantly, because people do not eat isolated nutrients.

The optimal dietary strategy for the prevention of chronic degenerative diseases remains a challenging and a highly relevant preventive health issue. Over the last years, numerous evidence on the existing relationship between nutrition and chronic degenerative diseases have led investigators to search for the optimal dietary pattern to maintain a good health status. Several models of diet have been imposed on public attention, but those that got the most interest are certainly Mediterranean and vegetarian diets. These dietary patterns seem to exert protective effects on blood pressure, lipid profiles, cardiovascular diseases and metabolic parameters.

The term Mediterranean diet has been widely used to describe the traditional dietary habits of people in Crete, South Italy, and other Mediterranean countries during the decade of the 1960s. Since the first data from the Seven Countries Study, several studies in different populations have established a beneficial role for the main components of the Mediterranean diet on the occurrence of cardiovascular diseases and chronic degenerative diseases. This dietary pattern is characterized by plentiful plant foods (fruits, vegetables, breads, other forms of cereals, beans, nuts, and seeds), olive oil as the principal source of fat, moderate amounts of dairy products (mainly cheese and yogurt), low to moderate amounts of fish and poultry, red meat in low amounts and wine consumed in low to moderate quantities, usually with meals.

The vegetarian diet is a diet that excludes the use of animal foods (meat, fish) in its fresh, preserved and/or processed. The increase in the number of vegetarians is attributable to health, ethical, environmental, and social concerns.

Recently, meta-analysis conducted by our group have revealed, in a population of over than 2 million of people, that a strict adherence to a Mediterranean dietary pattern is associated with a significant improvement in health status, as seen by a significant reduction in overall mortality (10%) and incidence and/or mortality from cardiovascular diseases (9%).

During the past few decades, there has been a gradual abandonment of this dietary pattern by the inhabitants of the Mediterranean basin, especially by the younger generations. Several factors have contributed to this nutrition transition, such as the enhanced commercial availability of food, the urbanization of life, and the overall improvement in socioeconomic conditions in Europe, which has increased the food and energy supply and made food (especially of animal origin) more affordable. Consumption of milk, meat and animal fat products increased in all Mediterranean countries. Moreover, a stressful lifestyle, less time spent on cooking, and the enhanced variety and availability of household appliances have also been proposed as determinants of nutrition transition.

Because of the growing evidence in favor of link between red and processed meat and cardiovascular disease risk, cancer and diabetes, the interest towards vegetarian diets has increased. In the last years, the number of subjects who began to adopt a vegetarian dietary pattern has enormously increased with respect to the past, when the population of vegetarians was limited only to few and selected cohorts. Such increase has been mainly attributed to the supposed beneficial effect of this dietary pattern versus the occurrence of diseases.

Health benefits of Mediterranean and vegetarian diets have been widely described in case-control and prospective cohort studies during the last 50 years. There are several beneficial nutrients that are abundant in these diets, such as monounsaturated fatty acids, high amounts of fiber and antioxidants and low intake of total and saturated fats. However, it is unclear whether established health benefits for vegetarians are attributable to the absence of meat in the diet, the increased consumption of particular food component(s) the pattern of foods eaten within the vegetarian diet or other healthy lifestyle components often associated with vegetarianism.

In a recent systematic review with meta-analysis carried out on over than 130,000 vegetarians, plant-based diet was associated with many health benefits. Main findings were that vegetarian diet determines, among case-control studies, lower levels of the most important risk factor for chronic disease, along with a reduced risk of occurrence for ischemic heart disease (-25%) when cohort prospective studies were taken into account.

Currently there are no randomized controlled trials to compare, in a high-risk group of patients with risk factors for cardiovascular disease, the efficacy of nutritional interventions based on Mediterranean and vegetarian dietary patterns. From this comparison it would may be possible to obtain interesting results in order to identify the optimal diet for prevention of cardiovascular diseases.

OBJECTIVES:

The primary aim of the study is to compare the effects of vegetarian diet on risk markers (anthropometric and biochemical measures) associated with cardio-metabolic diseases (CMD) after a 3-month dietary-intervention phase, compared with a Mediterranean diet.

Secondary objectives of the study are:

  • To improve knowledge about the pathophysiological role of vegetarian and Mediterranean diets in cardiovascular prevention
  • To evaluate the feasibility and degree of adherence to a dietary substitution with vegetarian diet in a omnivorous population
  • To evaluate the ability of a nutrition education intervention to reduce fresh and processed meat consumption in subjects at high cardiovascular risk, in order to enhance health and quality of life
  • To explore the impact of food prices on consumption and to evaluate the overall cost of buying food products in different dietary patterns

STUDY DESIGN The study is a randomized, open, cross-over trial designed to test whether a vegetarian diet would benefit the cardiovascular risk profile of the participants, compared with a Mediterranean diet.

The eligible participants are randomly divided into two groups, each assigned to either the experimental group (Group 1), which receives a vegetarian diet, or the control group (Group 2), which receives a Mediterranean diet. Following the first intervention phase, the subjects are crossed over in order to obtain the second intervention phase. Both diets are isocaloric and lasting three months each. The whole trial includes five clinical visits.

STUDY POPULATION Subjects in primary prevention with low-middle cardiovascular risk (1-5% according to the guidelines of the European Society of Cardiology), determined by the presence of BMI >o=25 kg/m2 and no more than other 2 concomitant metabolic risk factors.

Being tested
Vegetarian diet, Mediterranean diet
Keywords
diet, vegetarian, cardiovascular risk
Medical subject headings
Cardiovascular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vegetarian dietOther

    7-days dietary profile with an isocaloric Vegetarian diet for 3 months

  • Mediterranean dietOther

    7-days dietary profile with an isocaloric Mediterranean diet for 3 months

Study groups in NCT02641834
Study groupRoleWhat they receive
Veg GroupExperimentalGroup that starts with the Vegetarian diet
Receives: Other: Vegetarian diet; Other: Mediterranean diet
Med groupActive comparatorGroup that starts with the Mediterranean diet
Receives: Other: Vegetarian diet; Other: Mediterranean diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Body Weight From Baseline

    Changes in Body Weight From Baseline

    Measured: baseline and 6 months

Secondary outcomes (9)
  1. Changes in Fat Mass From Baseline

    Changes in fat mass from baseline

    Measured: baseline and 6 months

  2. Changes in BMI From Baseline

    Changes in BMI from baseline

    Measured: baseline and 6 months

  3. Changes in Total Cholesterol From Baseline

    Changes in total cholesterol from baseline

    Measured: baseline and 6 months

  4. Changes in LDL Cholesterol From Baseline

    Changes in LDL cholesterol from baseline

    Measured: baseline and 6 months

  5. Changes in Triglycerides From Baseline

    Changes in triglycerides from baseline

    Measured: baseline and 6 months

  6. Changes in Glucose From Baseline

    Changes in glucose from baseline

    Measured: baseline and 6 months

  7. Changes in TBARS From Baseline

    Changes in TBARS from baseline

    Measured: baseline and 6 months

  8. Changes in L-derived ROS From Baseline

    Changes in L-derived ROS from baseline

    Measured: baseline and 6 months

  9. Changes in Interleukin-17 From Baseline

    Changes in Interleukin-17 from baseline

    Measured: baseline and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2015 (estimated)
  2. Study startJan 2016
  3. Primary completionJul 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
118 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02641834
Sponsor's protocol ID
CAR-123-VEG
Acronym
CARDIVEG
Status last verified
Aug 2021
First submitted
22 Dec 2015
Last updated
27 Sep 2021
Data monitoring committee
No
Individual data sharing
Yes

Publications

  • Pagliai G, Tristan Asensi M, Dinu M, Cesari F, Bertelli A, Gori AM, Giusti B, Marcucci R, Sofi F, Colombini B. Effects of a dietary intervention with lacto-ovo-vegetarian and Mediterranean diets on apolipoproteins and inflammatory cytokines: results from the CARDIVEG study. Nutr Metab (Lond). 2024 Feb 1;21(1):9. doi: 10.1186/s12986-023-00773-w.

    PubMed 38302995
  • Ronca A, Pellegrini N, Pagliai G, Dinu M, Manfredini M, Incerti M, Favari E, Sofi F. Effects of a dietary intervention with Mediterranean vs lacto-ovo vegetarian diets on HDL function: Results from the CARDIVEG study. Nutr Metab Cardiovasc Dis. 2023 Mar;33(3):651-658. doi: 10.1016/j.numecd.2022.11.012. Epub 2022 Nov 24.

    PubMed 36642608
  • Sofi F, Dinu M, Pagliai G, Cesari F, Gori AM, Sereni A, Becatti M, Fiorillo C, Marcucci R, Casini A. Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet). Circulation. 2018 Mar 13;137(11):1103-1113. doi: 10.1161/CIRCULATIONAHA.117.030088. Epub 2018 Feb 26.

    PubMed 29483085
  • Sofi F, Dinu M, Pagliai G, Cesari F, Marcucci R, Casini A. Mediterranean versus vegetarian diet for cardiovascular disease prevention (the CARDIVEG study): study protocol for a randomized controlled trial. Trials. 2016 May 4;17(1):233. doi: 10.1186/s13063-016-1353-x.

    PubMed 27145958

Questions about this trial

What is this clinical trial studying?

A study testing Vegetarian diet and Mediterranean diet in people with Cardiovascular Disease, run by Azienda Ospedaliero-Universitaria Careggi at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 27 Sep 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Body Weight From Baseline (time frame: baseline and 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02641834, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in